Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Pharmacy|February 7, 2020
Physicians' acceptance of pharmacists' interventions in daily hospital practiceRianne J Zaal, Edwin W den Haak, Elrozy R Andrinopoulou, et al.
British Journal of Clinical Pharmacology|December 12, 2007
Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressantsMonique J Bijl, Loes E Visser, Albert Hofman, et al.
Therapeutic Drug Monitoring|August 26, 2009
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is notFerdi Sombogaard, Annemiek M A Peeters, Carla C Baan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 21, 2015
Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trialSebastiaan W Nij Bijvank, Willy Visser, Johannes J Duvekot, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxelFrederike K Engels, Albert J Ten Tije, Sharyn D Baker, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 1, 2018
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar AgentLars Erik Kristensen, Rieke Alten, Luis Puig, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalizationP Margreet G Filius, Inge C Gyssens, Irma M Kershof, et al.
Pharmacogenetics and Genomics|April 30, 2005
Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulantsLoes E Visser, Paul H Trienekens, Peter A G M De Smet, et al.
Therapeutic Drug Monitoring|April 1, 2009
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cellsPetra Glander, Ferdi Sombogaard, Klemens Budde, et al.
Breast Cancer Research and Treatment|February 4, 2009
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen usersMonique J Bijl, Ron H N van Schaik, Laureen A Lammers, et al.
Pageof 12